The DOI matches its Crossref record.
Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group
Open accessAbstract
Purpose: Single-institution case series have demonstrated the feasibility of the sentinel concept in cervical cancer. However, the diagnostic accuracy remains to be validated. We evaluated detection rate and diagnostic accuracy to predict the histopathologic pelvic nodal status in patients with cervical cancer of all stages. Patients and Methods: In a hypothesis-based, prospective, multicenter cohort study, patients underwent lymph node detection after labeling with technetium, patent blue, or both. After systematic pelvic and, if indicated, para-aortic node dissection, all lymph nodes were histopathologically examined. Detection rate, sensitivity, and negative predictive value (NPV) were calculated. Results: According to the protocol, 590 patients were eligible. Detection rate of pelvic sentinel nodes was 88.6% (95% CI, 85.8% to 91.1%) and was significantly higher for the combination of technetium and patent blue (93.5%; 95% CI, 90.3% to 96.0%). Of 106 patients with pelvic lymph node metastases, 82 had pelvic sentinel node metastases. The overall sensitivity was 77.4% (95% CI, 68.2% to 85.0%), which was lower than 90%, the predefined noninferiority margin (P < .001). Sensitivity in women with tumors ≤ 20 mm (90.9%), with bilateral detection (87.2%), or with both substances applied (80.3%) was higher compared with the total population. The overall NPV was 94.3% (95% CI, 91.6% to 96.4%) and was higher in patients with tumors ≤ 20 mm (99.1%; 95% CI, 96.6% to 100%) compared with patients with tumors more than 20 mm (88.5%; 95% CI, 82.9% to 92.8%; P < .001). Conclusion: In our cohort (all stages), sensitivity of the sentinel concept was low. However, patients with tumor diameter ≤ 20 mm may profit from this concept.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Koh, W.-J., Abu-Rustum, N. R., Bean, S., Bradley, K., Campos, S. M., Cho, K. R., Chon, H. S., Chu, C., Clark, R., Cohn, D., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0001 · Cited by 1,054
Bermudez, A., Bhatla, N., & Leung, E. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.06.004 · Cited by 657
Ballester, M., Dubernard, G., Lécuru, F., Heitz, D., Mathevet, P., Marret, H., Querleu, D., Golfier, F., Leblanc, E., Rouzier, R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70070-5 · Cited by 574
Cervical Cancer, Version 2.2015
Koh, W.-J., Greer, B. E., Abu-Rustum, N. R., Apte, S. M., Campos, S. M., Cho, K. R., Chu, C., Cohn, D., Crispens, M. A., Dorigo, O., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0055 · Cited by 332
Mechsner, S., Weichbrodt, M., Riedlinger, W. F. J., Bartley, J., Kaufmann, A. M., Schneider, A., & Kohler, C. (2008) · Human Reproduction · doi:10.1093/humrep/den259 · Cited by 69
Self-citation
Metadata
- Authors
- Altgassen, C., Hertel, H., Brandstädt, A., Köhler, C., Dürst, M., & Schneider, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-06-20
- Volume
- 26
- Issue
- 18
- Pages
- 2943-2951
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168351513
- Cited by
- 292
- References
- 0
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group. https://app.cochat.ai/papers/10.1200/jco.2007.13.8933
- The paper
- Altgassen, C., Hertel, H., Brandstädt, A., Köhler, C., Dürst, M., & Schneider, A. (2008). Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2007.13.8933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.